Financhill
Back

Anheuser-Busch InBev SA/NV Vs. Neurogene Industry Stock Comparison

Sell
32

BUD
Anheuser-Busch InBev SA/NV

Last Price:
$50.35
Seasonality Move:
0.1%
Sell
10

NGNE
Neurogene

Last Price:
$22.47
Seasonality Move:
18.83%
Sell
32
Anheuser-Busch InBev SA/NV (BUD) is a Sell

Is Anheuser-Busch InBev SA/NV a Buy, Sell or Hold?

  • The current Anheuser-Busch InBev SA/NV [BUD] share price is $50.54. The Score for BUD is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • BUD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
10
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $22.50. The Score for NGNE is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BUD Stock Price Chart

What is Anheuser-Busch InBev SA/NV's stock price today?

  • The Anheuser-Busch InBev SA/NV share price today is $50.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BUD is experiencing buying pressure, which is a positive indicator for future bullish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $22.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing slight buying pressure.

BUD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.78 Sell
Relative Strength Index (14 RSI): 25.72 Sell
Chaikin Money Flow: 1533125 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.57 - 54.97) Sell
Bollinger Bands (100): (55.39 - 64.79) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.45 Sell
Relative Strength Index (14 RSI): 39.99 Sell
Chaikin Money Flow: 17850 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.49 - 25.09) Buy
Bollinger Bands (100): (25.92 - 49.92) Sell

BUD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.52 Sell
20-day SMA: 52.73 Sell
50-day SMA: 57.26 Sell
200-day SMA: 60.54 Sell
8-day EMA: 51.22 Sell
20-day EMA: 52.78 Sell
50-day EMA: 55.97 Sell
200-day EMA: 59.67 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.96 Sell
20-day SMA: 23.45 Sell
50-day SMA: 36.87 Sell
200-day SMA: 37.81 Sell
8-day EMA: 22.84 Sell
20-day EMA: 25.05 Sell
50-day EMA: 31.73 Sell
200-day EMA: 34.89 Sell

Anheuser-Busch InBev SA/NV Earnings Growth & BUD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $0.30 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.

Anheuser-Busch InBev SA/NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):